Star Therapeutics
Company

Star Therapeutics

Biotechnology Research South San Francisco, California, United States 53 employees
Employees
53
Contacts
3
Emails
3
Phones
2

Star Therapeutics Overview

Headquarters
South San Francisco, California, United States
Industry
Biotechnology Research
Employees
53
Funding
90.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Star Therapeutics

Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in hematology and immunology. The company applies its expertise in antibody innovation to interrogate areas of biology that have been overlooked and have the potential for addressing multiple diseases with a single therapy. Our lead program, VGA039, has the potential to be a universal hemostatic therapy that can treat numerous bleeding disorders, starting with von Willebrand disease (VWD). As a subcutaneously self-administered antibody therapy with convenient dosing, VGA039 has the potential to significantly reduce the treatment burden for patients.

Star Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Star Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Monica Kamio Head of People, HR & Culture W/20-year
View
Lisa Hubbs
Email Phone
Jessica (Jess) Swann Global Biopharma Strategy
Email Phone
Jenny Lee Finance Professional with 20+ Years
Email

Employees by Management Level

Individual contributor 2 profiles
VP / Head 1 profile

Compare Similar Companies to Star Therapeutics